Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

CAPS Rating: 2 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Recs

0
Player Avatar HunNemo (66.58) Submitted: 6/7/2010 4:46:43 PM : Outperform Start Price: $3.31 ARIA Score: +378.74

Cramer pharma

Featured Broker Partners


Advertisement